iSpecimen Inc. (ISPC) vs Jaguar Health, Inc. (JAGX)

A side-by-side comparison of iSpecimen Inc. and Jaguar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ISPC vs JAGX

growth of $100 · dividends reinvested · last 4y
ISPC -99.1% (-69.6%/yr)JAGX -100.0% (-91.9%/yr)ISPC compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $1002022202320242025$1$0
ISPC JAGX

ISPC vs JAGX: by the numbers

  • •ISPC is the larger company ($3M vs $2M market cap).
  • •Both run net losses; JAGX's is the smaller (-131.76% vs -2449.04% net margin).
  • •JAGX grew revenue faster over the past five years (31.88% vs -46.70% CAGR).

Metrics side by side

Valuation

MetricISPCJAGX
P/S ratio5.780.09
P/B ratio1.550.37

Profitability

MetricISPCJAGX
Gross margin1.25%67.21%
Operating margin-465.42%-391.87%
Net margin-2449.04%-131.76%
ROE-657.69%-554.01%
ROIC-476.39%-110.81%

Growth (annualized)

MetricISPCJAGX
Revenue CAGR (5Y)-46.70%31.88%
Total return CAGR (5Y)-81.14%N/A

Frequently asked

Which has grown faster, ISPC or JAGX?
Over the past five years, JAGX grew revenue faster — ISPC at a -46.70% CAGR versus JAGX at 31.88%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.